Skip to main content

Advertisement

Table 1 Clinical characteristics of the patients analyzed

From: Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

Gender Number (%)
Male 12   70.6%
Female 5   29.4%
Histology Number (%)
Adenocarcinoma 2   11.8%
Squamous cell 13   76.4%
Other 2   11.8%
Initial cT Number (%)
cT1 1   5.9%
cT2 3   17.6%
cT3 4   23.5%
cT4 9   53%
Age (years) Median Range
54 41 – 78